Susquehanna International Group’s Aratana Therapeutics, Inc. PETX Stock Holding History

Susquehanna International Group’s Portfolio PETX Stock Details PETX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-18,949	Closed	-$98K	–	11283
2019 Q2	$98K	Buy	+18,949	New	+$85.2K	﹤0.01%	9611
2019 Q1	–	Sell	-28,490	Closed	-$123K	–	10422
2018 Q4	$175K	Buy	+28,490	New	+$174K	﹤0.01%	7866
2018 Q2	–	Sell	-11,620	Closed	-$58.6K	–	10843
2018 Q1	$51K	Sell	11,620 -2,406	-17%	-$10.7K	﹤0.01%	8950
2017 Q4	$74K	Buy	+14,026	New	+$85.8K	﹤0.01%	8807
2017 Q2	–	Sell	-624,611	Closed	-$3.84M	–	10191
2017 Q1	$3.31M	Buy	624,611 +556,281	+814%	+$3.76M	﹤0.01%	2886
2016 Q4	$491K	Buy	+68,330	New	+$552K	﹤0.01%	7037

Other funds holding PETX

Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return

ASN

Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

Susquehanna International Group's PETX Position: Q3 2019 in Review

Susquehanna International Group sold out of Aratana Therapeutics, Inc. (PETX) in Q3 2019, closing a stake of 18,949 shares — an estimated $98K sold.

Susquehanna International Group first reported a position in PETX in Q4 2016 and held it in 6 quarters. The position peaked at $3.31M in Q1 2017. 2 funds tracked by Wall St. Rank hold PETX as of Q3 2019.

Susquehanna International Group reported no remaining Aratana Therapeutics, Inc. position as of Q3 2019 after selling out during the quarter.
Susquehanna International Group sold 18,949 Aratana Therapeutics, Inc. shares in Q3 2019, an estimated $98K.
Susquehanna International Group first reported a position in Aratana Therapeutics, Inc. in Q4 2016 and held it in 6 quarters.
Susquehanna International Group's Aratana Therapeutics, Inc. position peaked at $3.31M in Q1 2017.
2 funds tracked by Wall St. Rank held Aratana Therapeutics, Inc. as of Q3 2019.

Based on Susquehanna International Group's 13F filing for Q3 2019, filed 14 Nov 2019.